Marksans Pharma Ltd has announced the following results for the quarter ended September 30, 2016:
The Unaudited Standalone results for the Quarter ended September 30, 2016
The Company has posted a net profit of Rs. 25.68 million for the quarter ended September 30, 2016 as compared to Rs. 285.37 million for the quarter ended September 30, 2015. Total Income has decreased from Rs. 1170.84 million for the quarter ended September 30, 2015 to Rs. 622.07 million for the quarter ended September 30, 2016.
The Consolidated Results are as follows:
The Unaudited Consolidated results for the Quarter ended September 30, 2016
The Group has posted a net profit after tax, minority interest and share of profit of associates of Rs. 4.10 million for the quarter ended September 30, 2016 as compared to Rs. 348.71 million for the quarter ended September 30, 2015. Total Income has decreased from Rs. 2555.43 million for the quarter ended September 30, 2015 to Rs. 1871.25 million for the quarter ended September 30, 2016.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
